Delivery Order SPE2DE24D0013-SPE2D626F77S8

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,208 on a firm fixed-price basis to Cepheid Inc. on January 5, 2026, with an ultimate completion date of January 12, 2026. The order, designated XPRSTREPA-10, represents a minimal-value procurement typical of supply chain replenishment activities. This delivery order is issued without a set-aside designation and is to be performed at Cepheid's headquarters in Sunnyvale, California. The award falls under the Defense Logistics Agency's medical supply chain operations, which manage procurement and distribution of critical medical supplies and equipment across Department of Defense and other federal healthcare operations.

Cepheid Inc. is a established federal supplier of advanced molecular diagnostic systems and reagents, with particular expertise in infectious disease detection through its GeneXpert diagnostic platform. The company maintains multiple indefinite delivery contracts with the Department of Veterans Affairs, including significant agreements with VISN 6 valued at approximately $32.8 million through September 2030 and VISN 17 valued at $6.7 million through December 2029, demonstrating its core role as a supplier of diagnostic testing reagents and assays across the federal healthcare system. This Defense Logistics Agency delivery order represents a routine replenishment draw consistent with Cepheid's established pattern of supplying molecular diagnostic test cartridges and reagents to federal healthcare agencies.